Screener
Kymera Therapeutics KYMR Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: Kymera Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333849
FAQ
- What is Kymera Therapeutics's net income?
- Kymera Therapeutics (KYMR) reported net income of -$61.21M in Q2 2026.
- How has Kymera Therapeutics's net income changed year-over-year?
- Kymera Therapeutics's net income increased by 20.1% year-over-year, from -$76.61M to -$61.21M.
- What is the long-term trend for Kymera Therapeutics's net income?
- Over 4 years (2021 to 2025), Kymera Therapeutics's net income has grown at a 32.8% compound annual growth rate (CAGR), from -$100.22M to -$311.35M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Kymera Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude